Glutathione S-transferase null and cholesteryl ester transfer protein TaqI B polymorphisms and lipid response to atorvastatin in Greek dyslipidaemic patients.
Goulas
Antonis
A
Department of Pharmacology, AHEPA Hospital, Thessaloniki, Greece. goulas@med.auth.gr
Kosmidou
Maria
M
Hatzitolios
Apostolos I
AI
Molyva
Dimitra
D
Fidani
Liana
L
Giannopoulos
Sotirios
S
Mirtsou
Vassiliki
V
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000069059:Atorvastatin; D053480:Cholesterol Ester Transfer Proteins / Q000172:deficiency / Q000235:genetics*; D005260:Female; D020868:Gene Silencing; D020022:Genetic Predisposition to Disease; D005838:Genotype; D005982:Glutathione Transferase / Q000172:deficiency / Q000235:genetics*; D006115:Greece; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic; D011758:Pyrroles / Q000627:therapeutic use*; D012016:Reference Values
D000924:Anticholesteremic Agents; C506642:CETP protein, human; D053480:Cholesterol Ester Transfer Proteins; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin; D005982:Glutathione Transferase